Literature DB >> 24634625

Sleep disordered breathing in group 1 pulmonary arterial hypertension.

Milan Minic1, John T Granton2, Clodagh M Ryan2.   

Abstract

STUDY
OBJECTIVES: To determine the prevalence and clinical predictors of sleep disordered breathing (SDB) and impact on outcomes in a cohort of patients with WHO group 1 pulmonary arterial hypertension (PAH).
METHODS: A retrospective, cross-sectional review of 52 consecutive subjects with known WHO group 1 PAH referred for assessment of possible SDB. Subjects had overnight polysomnography within 6 months of right heart catheterization performed as part of a routine clinical protocol.
RESULTS: SDB was present in 71% of the PAH patients: 56% had OSA and 44% CSA. Older age and subjective sleepiness as assessed by the Epworth Sleepiness Scale score > 10 were predictive of SDB. A high prevalence of OSA occurred in both male (50%) and female (60%) subjects. No differences in cardiopulmonary hemodynamics or survival between those with and without SDB were observed.
CONCLUSIONS: This high prevalence of SDB in the PAH population suggests that systematic screening and testing is important in this group. Further studies are necessary to determine the pathophysiological effect of SDB and potential impact of SDB treatment in this population. CITATION: Minic M; Granton JT; Ryan CM. Sleep disordered breathing in group 1 pulmonary arterial hypertension.

Entities:  

Keywords:  Obstructive sleep apnea; apnea-hypopnea index; central sleep apnea; pulmonary arterial hypertension; sleep disordered breathing

Mesh:

Year:  2014        PMID: 24634625      PMCID: PMC3927433          DOI: 10.5664/jcsm.3528

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  37 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Nocturnal hypoxemia is common in primary pulmonary hypertension.

Authors:  A L Rafanan; J A Golish; D S Dinner; L K Hague; A C Arroliga
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

4.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome.

Authors:  E Bady; A Achkar; S Pascal; E Orvoen-Frija; J P Laaban
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

5.  Prevalence of sleep-disordered breathing in women: effects of gender.

Authors:  E O Bixler; A N Vgontzas; H M Lin; T Ten Have; J Rein; A Vela-Bueno; A Kales
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

6.  Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr.

Authors:  J Durán; S Esnaola; R Rubio; A Iztueta
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

7.  Nocturnal periodic breathing in primary pulmonary hypertension.

Authors:  R Schulz; G Baseler; H A Ghofrani; F Grimminger; H Olschewski; W Seeger
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

8.  Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study.

Authors:  Terry Young; Eyal Shahar; F Javier Nieto; Susan Redline; Anne B Newman; Daniel J Gottlieb; Joyce A Walsleben; Laurel Finn; Paul Enright; Jonathan M Samet
Journal:  Arch Intern Med       Date:  2002-04-22

Review 9.  Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines.

Authors:  Charles W Atwood; Douglas McCrory; Joe G N Garcia; Steven H Abman; Gregory S Ahearn
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

10.  Sleep-related breathing disorders in patients with pulmonary hypertension.

Authors:  Silvia Ulrich; Manuel Fischler; Rudolf Speich; Konrad E Bloch
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

View more
  20 in total

Review 1.  The Role of Big Data in the Management of Sleep-Disordered Breathing.

Authors:  Rohit Budhiraja; Robert Thomas; Matthew Kim; Susan Redline
Journal:  Sleep Med Clin       Date:  2016-03-16

2.  Continuous positive airways pressure and uvulopalatopharyngoplasty improves pulmonary hypertension in patients with obstructive sleep apnoea.

Authors:  Maurizio Marvisi; Maurizio Giuseppe Vento; Laura Balzarini; Chiara Mancini; Chiara Marvisi
Journal:  Lung       Date:  2015-02-14       Impact factor: 2.584

3.  Pulmonary artery dilatation and obstructive sleep apnea.

Authors:  Joseph Simonson; Harley Greenberg; Arunabh Talwar
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 4.  Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.

Authors:  Nils P Nickel; Ke Yuan; Peter Dorfmuller; Steeve Provencher; Yen-Chun Lai; Sebastien Bonnet; Eric D Austin; Carl D Koch; Alison Morris; Frédéric Perros; David Montani; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

5.  Validity of transit time-based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers.

Authors:  Sara Becker; Jens Spiesshoefer; Tobias Brix; Izabela Tuleta; Michael Mohr; Michele Emdin; Matthias Boentert; Alberto Giannoni
Journal:  Sleep Breath       Date:  2019-05-02       Impact factor: 2.816

6.  Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing.

Authors:  Brandon T Nokes; Hassan A Raza; Rodrigo Cartin-Ceba; Phillip J Lyng; Lois E Krahn; Lewis Wesselius; Clinton E Jokerst; Sarah B Umar; W Leroy Griffing; Matthew R Neville; Atul Malhotra; James M Parish
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

7.  Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway.

Authors:  Jie Ren; Wei Liu; Guang-Cai Li; Meng Jin; Zhen-Xi You; Hui-Guo Liu; Yi Hu
Journal:  Curr Med Sci       Date:  2018-06-22

8.  Pulmonary artery hemodynamics are associated with duration of nocturnal desaturation but not apnea-hypopnea index.

Authors:  Bilal Samhouri; Mrinalini Venkatasaburamini; Hugo Paz Y Mar; Manshi Li; Reena Mehra; Neal F Chaisson
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

9.  Usefulness of Low Cardiac Index to Predict Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jeremy E Orr; William R Auger; Pamela N DeYoung; Nick H Kim; Atul Malhotra; Robert L Owens
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

10.  Obstructive sleep apnea in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Xue Yu; Zhiwei Huang; Yi Zhang; Zhihong Liu; Qin Luo; Zhihui Zhao; Qing Zhao; Liu Gao; Qi Jin; Lu Yan
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.